Form 4 for DGX Quest Diagnostics
Accepted 2022-02-25 00:00:00 ET · period of report 2022-02-23 · accession 0001022079-22-000013 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-02-25 | 2022-02-23 | DGX | Davis J. E. | EVP-Gen. Diagnostics, CEO Elect | F - Tax | $130.13 | -2,436 | 48.2K | -5% | -$317.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-23 | F | D | 724 | $130.23 | 47,495 | D | — | — | (F1) Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units. |
| 2 | Common | Common Stock | 2022-02-23 | F | D | 1,712 | $130.09 | 48,219 | D | — | — | (F1) Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units. |